[ad_1]
BERKELEY (CBS SF) – A former cancer researcher from the University of Berkeley received the Nobel Prize in Physiology or Medicine 2018 for his groundbreaking work that began on the Berkeley campus and continued after his stint at the MD Anderson Cancer Center of the University of Texas.
James Allison, who for 20 years was an immunologist at UC Berkeley conducting basic cancer research, shared this prestigious award Monday with Tasuku Honjo from Kyoto University in Japan.
Men received the award "for their discovery of cancer treatment by inhibiting negative immune regulation".
Allison's groundbreaking research, 70 years ago, focused on T cells and the ability to adapt their disease control trends to cancer cells in the body.
According to UC Berkeley, the monoclonal antibody treatment was approved by the Food and Drug Administration in 2011 to treat malignant melanoma and resulted in several related treatments currently used against lung cancer, prostate cancer and others.
"Targeted therapies do not cure cancer, but immunotherapy is curative. That's why many view it as the most important progress in a generation, "said Allison in an interview in 2015." It's clear that immunotherapy has now taken its place with surgery, chemotherapy and the radiotherapy as a reliable and objective way to treat cancer. "
Source link
